Latest H5N1 clinical trials Stories
For the first time, a malaria vaccine that uses the entire malaria parasite has proven safe and shown promise to produce a strong immune response in a clinical trial.
Using live but weakened malaria parasites as the basis of a vaccine represents a potentially encouraging anti-malaria strategy.
New research from the Trudeau Institute may help to explain why live attenuated influenza vaccine (LAIV), commonly known as FluMist, elicits protection.
ATLANTA, Aug. 16, 2011 /PRNewswire/ -- GeoVax Labs, Inc.
SAN DIEGO, Aug.
QUEBEC CITY, QC, Aug. 12, 2011 /PRNewswire/ - Medicago Inc.
- An aromatic woolly plant (Origanum dictamnus) native to Crete, formerly believed to have magical powers.